List of insiders holdings for CymaBay Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Avoro Capital Advisors LLC Aghazadeh Behzad 10% Owner |
2024-02-14 09:09:24 | 16,337,739 0 |
16,337,739 | Form 13G |
| 2 | Versant Venture Capital II LP Versant Affiliates Fund II-A LP Versant Side Fund II LP 10% Owner |
2016-02-09 17:42:19 | 1,123,600 0 |
1,123,600 | Form 13G |
| 3 | ALTA BIOPHARMA PARTNERS III LP ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC 10% Owner |
2016-02-12 17:20:33 | 1,093,100 0 |
1,093,100 | Form 13G |
| 4 | KIM DENNIS D Chief Medical Officer |
2023-04-17 19:24:09 | 472,019 0 |
472,019 | Form 4 |
| 5 | STUART LEWIS J Chief Commercial Officer |
2023-01-27 16:26:27 | 215,000 0 |
215,000 | Form 4 |
| 6 | Van Wart Harold President and CEO |
2017-01-23 18:32:29 | 200,000 0 |
200,000 | Form 4 |
| 7 | Boudes Pol F Chief Medical Officer |
2019-01-31 17:28:22 | 138,312 0 |
138,312 | Form 4 |
| 8 | Menold Daniel Vice President, Finance |
2024-01-16 19:07:39 | 135,109 0 |
135,109 | Form 4 |
| 9 | Martin Robert L. SVP, Nonclinical & Manuf. |
2018-01-26 17:09:09 | 125,000 0 |
125,000 | Form 4 |
| 10 | OMara Patrick J. SVP, Business Development |
2018-01-26 17:16:06 | 125,000 0 |
125,000 | Form 4 |
| 11 | Rosemark Kirk V.P. Regulatory & Quality |
2017-01-23 18:28:10 | 50,000 0 |
50,000 | Form 4 |
| 12 | von Emster Kurt Director |
2020-05-19 17:23:56 | 49,245 0 |
49,245 | Form 4 |
| 13 | TRUEX PAUL F Director |
2021-01-28 15:00:52 | 32,000 0 |
32,000 | Form 4 |
| 14 | Weiland Robert J. Director |
2019-01-31 17:23:35 | 27,705 0 |
27,705 | Form 4 |
| 15 | STEIN EVAN A. Director |
2019-01-31 17:22:14 | 27,705 0 |
27,705 | Form 4 |
| 16 | Booth Robert F. Director |
2019-01-31 17:19:02 | 27,705 0 |
27,705 | Form 4 |
| 17 | LANGE LOUIS G Director |
2015-06-30 18:02:55 | 9,000 0 |
9,000 | Form 4 |
| 18 | Kumar Hari Director |
2015-06-30 18:00:00 | 9,000 0 |
9,000 | Form 4 |
| 19 | PENHOET EDWARD Director |
2015-01-08 19:33:42 | 9,000 0 |
9,000 | Form 4 |
| 20 | Loewy Caroline M Director |
2024-03-22 17:09:21 | 0 0 |
0 | Form 4 |
| 21 | GOLDFISCHER CARL Director |
2019-02-08 20:21:09 | 0 0 |
0 | Form 4 |
| 22 | McWherter Charles President of R&D |
2024-03-22 17:06:11 | 0 0 |
0 | Form 4 |
| 23 | Lefebvre Eric Director |
2024-03-22 17:05:48 | 0 0 |
0 | Form 4 |
| 24 | Dorling Janet Director |
2024-03-22 17:03:33 | 0 0 |
0 | Form 4 |
| 25 | Shantharam Harish Chief Financial Officer |
2024-03-22 17:03:16 | 0 0 |
0 | Form 4 |
| 26 | Dickinson Klara Chief Regulatory Officer |
2024-03-22 17:02:09 | 0 0 |
0 | Form 4 |
| 27 | Quinlan Paul T General Counsel |
2024-03-22 16:59:26 | 0 0 |
0 | Form 4 |
| 28 | Wills Robert James Director |
2024-03-22 16:55:35 | 0 0 |
0 | Form 4 |
| 29 | Shah Sujal Chief Executive Officer |
2024-03-22 16:55:22 | 0 0 |
0 | Form 4 |
| 30 | WIGGANS THOMAS G Director |
2024-03-22 16:54:55 | 0 0 |
0 | Form 4 |
| 31 | EMSTER KURT VON Director |
2024-03-22 16:51:11 | 0 0 |
0 | Form 4 |